相关实验视频

Updated: May 10, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

全癌症分析显示,PRRT4是AML的潜在预后因素

Wenqiong Xiang¹, Fangjun Chen², Hao Zhou¹

¹Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

Hematology (Amsterdam, Netherlands)

|April 25, 2025

概括

富含林的跨膜蛋白4 (PRRT4) 在不同癌症中表现多样,是几种癌症整体存活的潜在预后标志物. PRRT4也可能是恶性瘤的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

富含林的跨膜蛋白4 (PRRT4) 尚未得到充分研究,初步证据表明它在胃癌预后中的作用.
关于PRRT4在癌症中的更广泛影响的研究有限.

研究的目的:

研究PRRT4基因在一系列癌症类型 (胰腺癌) 的预后价值.
探索PRRT4与临床因素,突变,甲基化和免疫透的相关性.

主要方法:

使用了来自TCGA,GTEx,CCLE,cBioPortal,HPA和TIMER 2.0.0的多omics数据.
在AML细胞上进行了多变量分析,RT-qPCR和体外实验 (PRRT4淘汰).

主要成果:

PRRT4的表达有所变化 (在10种癌症中低,在3种癌症中高) 并与瘤阶段,年龄和性别相关.
在LAML,PAAD,SKCM,STAD,THYM和UVM中确定PRRT4作为整体生存的独立预后因素.
在UCEC中,PRRT4突变很常见;表达与DNA甲基化和免疫透相关.
在THP1细胞中,PRRT4的淘汰增强了增殖和减少了亡.

结论:

PRRT4显示出作为急性髓性白血病 (AML) 的独立预后生物标志物的潜力.
PRRT4可以作为各种恶性瘤的潜在治疗标和预后标志物.

关键词:

在AML,AML就是AML.在PRRT4中,使用的是PRRT4.胰腺癌是一种癌症.总体存活率总体存活率预后预后预后

更多相关视频

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...